David Grandy | Senior Scientist
Merck

David Grandy, Senior Scientist, Merck

David is a Senior Scientist in Protein Engineering at Merck, he has worked with bispecific antibodies in various formats for multiple therapeutic areas over the last 5 years. Before joining Merck he received his Master’s degree in Biochemistry and Structural Biology from Cornell University, where he worked on structural studies for receptor tyrosine kinases

Appearances:



Festival of Biologics Day 2 @ 17:50

Anti-CD3 screening: Bispecific antibody assembly workflow using controlled Fab-arm Exchange

Anti-CD3 antibody screening platform for TCE potency

Automation platform for bispecific antibody assembly

TCE potency decoupled from T-cell binding

last published: 25/Mar/25 09:15 GMT

back to speakers